Cystic fibrosis medicine savings

A local MP says putting medicine for patients with cystic fibrosis on the pharmaceutical benefits scheme will save them and their families thousands each year.

From December SYMDEKO will be listed for patients over 12, while the current listing of ORKAMBI will be expanded for kids aged between two and five.

Member for Mallee ANNE WEBSTER says it's important to provide access to the new medicines.